CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
PD-L1 Testing in Gastric Cancer by the Combined Positive Score of the 22C3 PharmDx and SP263 Assay with Clinically Relevant Cut-offs
Yujun Park, Jiwon Koh, Hee Young Na, Yoonjin Kwak, Keun-Wook Lee, Sang-Hoon Ahn, Do Joong Park, Hyung-Ho Kim, Hye Seung Lee
Cancer Research and Treatment. 2020;52(3):661-670.   Published online 2020 January 10    DOI: https://doi.org/10.4143/crt.2019.718

Excel Download

PD-L1 Testing in Gastric Cancer by the Combined Positive Score of the 22C3 PharmDx and SP263 Assay with Clinically Relevant Cut-offs
Cancer Research and Treatment. 2020;52(3):661-670   Crossref logo
Link1 Link2 Link3

PD-L1 expression in gastric cancer: interchangeability of 22C3 and 28-8 pharmDx assays for responses to immunotherapy
Modern Pathology. 2021;34(9):1719-1727   Crossref logo
Link1 Link2 Link3

Analytical comparison of a PD-L1 22C3 antibody laboratory-developed test (LDT) protocol on the benchmark XT and PD-L1 IHC 22C3 pharmdx: analysis of pan-tumour and oesophageal cancer samples
Pathology. 2021;53:S47   Crossref logo
Link1 Link2

P2.01-049 A Comparative Study of PD-L1 IHC 28-8 pharmDx and PD-L1 IHC 22C3 pharmDx on Malignancies from the Lung
Journal of Thoracic Oncology. 2017;12(1):S815-S816   Crossref logo
Link1 Link2

154P Investigation of PD-L1 expression and tislelizumab efficacy in gastroesophageal adenocarcinoma using a novel tumor and immune cell score with VENTANA PD-L1 (SP263) assay and Combined Positive Score (CPS)
Annals of Oncology. 2020;31:S300   Crossref logo
Link1 Link2

P2.09-14 Evaluation on Inter-Assay Consistency and Inter-Reader Precision for PD-L1 Assays: Ventana SP263 and Dako 22C3 in Non-Small Cell Lung Cancer
Journal of Thoracic Oncology. 2019;14(10):S774   Crossref logo
Link1 Link2

Tumor PD-L1 expression in malignant pleural and peritoneal mesothelioma by Dako PD-L1 22C3 pharmDx and Dako PD-L1 28-8 pharmDx assays
Human Pathology. 2019;87:11-17   Crossref logo
Link1 Link2

P37.26 Comprehensive Comparison of 22C3 and SP263 PD-L1 Expression using Routine Clinical and Conditioned Archives of Non-Small-Cell Lung Cancer
Journal of Thoracic Oncology. 2021;16(3):S453   Crossref logo
Link1 Link2

Correlation of PD-L1 Expression Tested by 22C3 and SP263 in Non-Small Cell Lung Cancer and Its Prognostic Effect onEGFRMutation–Positive Lung Adenocarcinoma
Tuberculosis and Respiratory Diseases. 2020;83(1):51   Crossref logo
Link1 Link2 Link3

MA13.01 CT-Guided Transthoracic Needle Biopsy for Evaluation of PD-L1 Expression: Comparison of 22C3 and SP263 Assays
Journal of Thoracic Oncology. 2018;13(10):S399-S400   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.